Correspondence Vancomycin Minimum Inhibitory Concentrations and Outcome in Patients With Severe Staphylococcus aureus Infection

point out in their excellent commentary [1], there are many unresolved issues in the measurement and clinical interpreta-tion of vancomycin minimum inhibitory concentrations (MICs). There is, however, one major omission from their otherwise comprehensive review of published, peer-reviewed outcome studies versus MIC in serious methicillin-resistant Staphylococ-cus aureus (MRSA) infection: the results that have recently been reported from 2 double-blind, randomized, phase III, non